Harmonization in laboratory medicine: more than clinical chemistry?

被引:38
作者
Plebani, Mario [1 ]
机构
[1] Univ Hosp Padova, Dept Lab Med, Via Nicolo Giustiniani 2, I-35128 Padua, Italy
关键词
extra-analytical phases; harmonization; laboratory information; patient outcomes; quality; standardization; EFLM WORKING GROUP; PREANALYTICAL PHASE; EUROPEAN FEDERATION; PERFORMANCE SPECIFICATIONS; METROLOGICAL TRACEABILITY; QUALITY INDICATORS; STANDARDIZATION; IMMUNOASSAYS; SERUM; PATHOLOGY;
D O I
10.1515/cclm-2017-0865
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The goal of harmonizing laboratory information is to contribute to quality in patient care, ultimately improving upon patient outcomes and safety. The main focus of harmonization and standardization initiatives has been on analytical processes within the laboratory walls, clinical chemistry tests in particular. However, two major evidences obtained in recent years show that harmonization should be promoted not only in the analytical phase but also in all steps of the testing process, encompassing the entire field of laboratory medicine, including innovative areas (e.g. "omics") rather than just conventional clinical chemistry tests. A large body of evidence demonstrates the vulnerability of the extra-analytical phases of the testing cycle. Because only "good biological samples" can assure good analytical quality, a closer interconnection between the different phases of the cycle is needed. In order to provide reliable and accurate laboratory information, harmonization activities should cover all steps of the cycle from the "pre-pre-analytical" phase (right choice of test at right time for right patient) through the analytical steps (right results with right report) to the "post-post-analytical" steps (right and timely acknowledgment of laboratory information, right interpretation and utilization with any necessary advice as to what to do next with the information provided). In addition, modern clinical laboratories are performing a broad menu of hundreds of tests, covering both traditional and innovative subspecialties of the discipline. In addition, according to a centered viewpoint, harmonization initiatives should not be addressed exclusively to clinical chemistry tests but should also include all areas of laboratory medicine.
引用
收藏
页码:1579 / 1586
页数:8
相关论文
共 71 条
  • [1] How to achieve harmonisation of laboratory testing - The complete picture
    Aarsand, Aasne K.
    Sandberg, Sverre
    [J]. CLINICA CHIMICA ACTA, 2014, 432 : 8 - 14
  • [2] National Survey of Adult and Pediatric Reference Intervals in Clinical Laboratories across Canada: A Report of the CSCC Working Group on Reference Interval Harmonization
    Adeli, Khosrow
    Higgins, Victoria
    Seccombe, David
    Collier, Christine P.
    Balion, Cynthia M.
    Cembrowski, George
    Venner, Allison A.
    Shaw, Julie
    [J]. CLINICAL BIOCHEMISTRY, 2017, 50 (16-17) : 925 - 935
  • [3] [Anonymous], NATL MINIMUM RETESTI
  • [4] Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling
    Basso, Daniela
    Padoan, Andrea
    Laufer, Thomas
    Aneloni, Vittorio
    Moz, Stefania
    Schroers, Hannah
    Pelloso, Michela
    Saiz, Anna
    Krapp, Medea
    Fogar, Paola
    Cornoldi, Paola
    Zambon, Carlo-Federico
    Rossi, Elisa
    La Malfa, Marco
    Marotti, Alberto
    Brefort, Thomas
    Weis, Tanja M.
    Katus, Hugo A.
    Plebani, Mario
    [J]. CLINICAL BIOCHEMISTRY, 2017, 50 (4-5) : 186 - 193
  • [5] BELK WP, 1947, AM J CLIN PATHOL, V17, P853
  • [6] High-titre circulating tissue transglutaminase-2 antibodies predict small bowel villous atrophy, but decision cut-off limits must be locally validated
    Beltran, L.
    Koenig, M.
    Egner, W.
    Howard, M.
    Butt, A.
    Austin, M. R.
    Patel, D.
    Sanderson, R. R.
    Goubet, S.
    Saleh, F.
    Lavender, J.
    Stainer, E.
    Tarzi, M. D.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 176 (02) : 190 - 198
  • [7] Wrong blood in tube - potential for serious outcomes: can it be prevented?
    Bolton-Maggs, Paula H. B.
    Wood, Erica M.
    Wiersum-Osselton, Johanna C.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (01) : 3 - 13
  • [8] Performance criteria for combined uncertainty budget in the implementation of metrological traceability
    Braga, Federica
    Infusino, Ilenia
    Panteghini, Mauro
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (06) : 905 - 912
  • [9] Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility
    Brown, Derek
    MacGowan, Alasdair
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (02) : 183 - 185
  • [10] Pilot study on harmonization of cardiac troponin I immunoassays using patients and quality control plasma samples. On behalf of the Italian Section of the European Ligand Assay Society (ELAS) and of the Study Group on Cardiovascular Biomarkers of the Society Italiana di Biochimica Clinica (SIBioC)
    Clerico, Aldo
    Ripoli, Andrea
    Masotti, Silvia
    Prontera, Concetta
    Storti, Simona
    Fortunato, Antonio
    Buzzi, Paola
    Casagranda, Ivo
    Franzini, Maria
    Ndreu, Rudina
    Zucchelli, Gian Carlo
    Zaninotto, Martina
    Plebani, Mario
    [J]. CLINICA CHIMICA ACTA, 2016, 456 : 42 - 48